• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻连蛋白新的肝素结合结构域的鉴定

Identification of novel heparin-binding domains of vitronectin.

作者信息

Liang O D, Rosenblatt S, Chhatwal G S, Preissner K T

机构信息

GBF-National Research Center for Biotechnology/Technical University Braunschweig, Germany.

出版信息

FEBS Lett. 1997 Apr 28;407(2):169-72. doi: 10.1016/s0014-5793(97)00330-x.

DOI:10.1016/s0014-5793(97)00330-x
PMID:9166893
Abstract

Vitronectin is a multifunctional serum protein which provides a unique regulatory link between cell adhesion, humoral defense mechanism and the hemostatic system, and the heparin-binding properties of vitronectin are thought to have participated in various functional aspects. In addition to the carboxy-terminal glycosaminoglycan-binding motif, we report on two novel heparin-binding domains which were identified using phage display technique. One heparin-binding domain is located between amino acids Asp82 and Cys137 at the end of the connector region, while the other is in the second hemopexin-type repeat, between amino acids Lys175 and Asp219 of the vitronectin molecule. Our findings may shed new light to the activities of vitronectin and its binding to cells, which could not be explained solely on the basis of the known heparin-binding domain.

摘要

玻连蛋白是一种多功能血清蛋白,它在细胞黏附、体液防御机制和止血系统之间提供了独特的调节联系,并且玻连蛋白的肝素结合特性被认为参与了多个功能方面。除了羧基末端糖胺聚糖结合基序外,我们还报道了利用噬菌体展示技术鉴定出的两个新的肝素结合结构域。一个肝素结合结构域位于连接区末端的天冬氨酸82和半胱氨酸137之间的氨基酸残基处,而另一个位于玻连蛋白分子第二个血红素结合蛋白样重复序列中,在赖氨酸175和天冬氨酸219之间。我们的发现可能为玻连蛋白的活性及其与细胞的结合提供新的线索,而这仅基于已知的肝素结合结构域无法解释。

相似文献

1
Identification of novel heparin-binding domains of vitronectin.玻连蛋白新的肝素结合结构域的鉴定
FEBS Lett. 1997 Apr 28;407(2):169-72. doi: 10.1016/s0014-5793(97)00330-x.
2
Orientation of heparin-binding sites in native vitronectin. Analyses of ligand binding to the primary glycosaminoglycan-binding site indicate that putative secondary sites are not functional.天然玻连蛋白中肝素结合位点的定位。对配体与主要糖胺聚糖结合位点结合的分析表明,假定的次要位点没有功能。
J Biol Chem. 1999 Mar 5;274(10):6432-42. doi: 10.1074/jbc.274.10.6432.
3
The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling.玻连蛋白的肝素结合结构域是增强胰岛素样生长因子-I信号传导所必需的区域。
Mol Endocrinol. 2006 Apr;20(4):881-92. doi: 10.1210/me.2005-0382. Epub 2005 Dec 1.
4
Heparin binding domain in vitronectin is required for oligomerization and thus enhances integrin mediated cell adhesion and spreading.纤连蛋白中的肝素结合域是寡聚化所必需的,从而增强整合素介导的细胞黏附和铺展。
FEBS Lett. 2010 Aug 4;584(15):3287-91. doi: 10.1016/j.febslet.2010.06.023. Epub 2010 Jun 19.
5
The role of carboxy-terminal glycosaminoglycan-binding domain of vitronectin in cytoskeletal organization and migration of endothelial cells.玻连蛋白羧基末端糖胺聚糖结合结构域在内皮细胞细胞骨架组织和迁移中的作用。
Cell Adhes Commun. 1996 Nov;4(4-5):317-25. doi: 10.3109/15419069609010775.
6
Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor.玻连蛋白的有限纤溶酶蛋白水解作用。将黏附蛋白鉴定为形态调节因子和血管抑素结合因子。
Eur J Biochem. 1996 Mar 1;236(2):682-8. doi: 10.1111/j.1432-1033.1996.0682d.x.
7
The hemopexin-type repeats of human vitronectin are recognized by Streptococcus pyogenes.化脓性链球菌可识别人类玻连蛋白的血红素结合蛋白型重复序列。
Biochem Biophys Res Commun. 1997 May 19;234(2):445-9. doi: 10.1006/bbrc.1997.6663.
8
Characterization of the ligand binding activities of vitronectin: interaction of vitronectin with lipids and identification of the binding domains for various ligands using recombinant domains.玻连蛋白的配体结合活性表征:玻连蛋白与脂质的相互作用以及使用重组结构域鉴定各种配体的结合结构域。
Biochemistry. 1998 May 5;37(18):6351-60. doi: 10.1021/bi972247n.
9
Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC).黏附蛋白与反黏附蛋白相互作用对细胞黏附的差异调节:玻连蛋白与骨连接蛋白(BM40,SPARC)结合的特性
Biochem J. 1997 May 15;324 ( Pt 1)(Pt 1):311-9. doi: 10.1042/bj3240311.
10
Complement inhibition by human vitronectin involves non-heparin binding domains.人玻连蛋白对补体的抑制作用涉及非肝素结合结构域。
Clin Exp Immunol. 1995 Jul;101(1):136-41. doi: 10.1111/j.1365-2249.1995.tb02289.x.

引用本文的文献

1
The Emerging Roles of Extracellular Chaperones in Complement Regulation.细胞外伴侣分子在补体调控中的新兴作用。
Cells. 2022 Dec 2;11(23):3907. doi: 10.3390/cells11233907.
2
Colonization and Infection of Indwelling Medical Devices by with an Emphasis on Orthopedic Implants.定植和感染与骨科植入物相关。
Int J Mol Sci. 2022 May 25;23(11):5958. doi: 10.3390/ijms23115958.
3
The iron-regulated surface determinant B (IsdB) protein from acts as a receptor for the host protein vitronectin.来自 的铁调节表面决定簇 B(IsdB)蛋白作为宿主蛋白 vitronectin 的受体。
J Biol Chem. 2020 Jul 17;295(29):10008-10022. doi: 10.1074/jbc.RA120.013510. Epub 2020 Jun 4.
4
Vitronectin Binds to a Specific Stretch within the Head Region of Yersinia Adhesin A and Thereby Modulates Yersinia enterocolitica Host Interaction.玻连蛋白与耶尔森氏菌粘附素A头部区域内的特定片段结合,从而调节小肠结肠炎耶尔森氏菌与宿主的相互作用。
J Innate Immun. 2017;9(1):33-51. doi: 10.1159/000449200. Epub 2016 Nov 1.
5
Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins.登革病毒NS1通过与玻连蛋白和补体末端蛋白相互作用抑制膜攻击复合物
J Virol. 2016 Oct 14;90(21):9570-9581. doi: 10.1128/JVI.00912-16. Print 2016 Nov 1.
6
Sialylation of vitronectin regulates stress fiber formation and cell spreading of dermal fibroblasts via a heparin-binding site.玻连蛋白的唾液酸化通过一个肝素结合位点调节真皮成纤维细胞的应力纤维形成和细胞铺展。
Glycoconj J. 2016 Apr;33(2):227-36. doi: 10.1007/s10719-016-9660-8. Epub 2016 Mar 15.
7
Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif.微生物免疫逃逸的保守模式:不同来源的致病微生物通过单一共同基序靶向人类末端补体抑制剂玻连蛋白。
PLoS One. 2016 Jan 25;11(1):e0147709. doi: 10.1371/journal.pone.0147709. eCollection 2016.
8
Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack.铜绿假单胞菌利用二氢硫辛酰胺脱氢酶(Lpd)与人末端途径调节因子玻连蛋白和聚集素结合,以抑制末端途径补体攻击。
PLoS One. 2015 Sep 14;10(9):e0137630. doi: 10.1371/journal.pone.0137630. eCollection 2015.
9
Identification and therapeutic potential of a vitronectin binding region of meningococcal msf.脑膜炎球菌msf的玻连蛋白结合区域的鉴定及其治疗潜力
PLoS One. 2015 Mar 31;10(3):e0124133. doi: 10.1371/journal.pone.0124133. eCollection 2015.
10
In vitro selection of RNA aptamers directed against protein E: a Haemophilus influenzae adhesin.针对蛋白E(一种流感嗜血杆菌粘附素)的RNA适体的体外筛选
Mol Biotechnol. 2014 Aug;56(8):714-25. doi: 10.1007/s12033-014-9749-x.